Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 8, Issue 10, 2014, Pages

  Kumar, Rajiv ^a,b   Singh, Neetu ^a   Gautam, Shalini ^a   Singh, Om Prakash ^a   Gidwani, Kamlesh ^a,c   Rai, Madhukar ^a   Sacks, David ^d   Sundar, Shyam ^a   Nylén, Susanne ^e  

^a BANARAS HINDU UNIVERSITY   (India)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF TURKU   (Finland)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; PARASITE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; BLOOD CULTURE; CD4+ T LYMPHOCYTE; COMPLEMENT INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SPLEEN; SPLEEN CELL; VISCERAL LEISHMANIASIS; ADOLESCENT; CELL DIVISION; CHILD; CYTOLOGY; GENETICS; IMMUNOLOGY; LEISHMANIA; METABOLISM; MIDDLE AGED; PARASITOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CHILD; FEMALE; HUMANS; INTERFERON-GAMMA; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; SPLEEN; YOUNG ADULT;

EID: 84920398988     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003198     Document Type: Article

References (25)

1. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM, (1989) Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 169: 59–72.
2. Scott P, Pearce E, Cheever AW, Coffman RL, Sher A, (1989) Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev 112: 161–182.
3. Kima PE, Soong L, (2013) Interferon gamma in leishmaniasis. Front Immunol 4: 156.
4. Nylen S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, et al. (2007) Splenic accumulation of IL-10 mrna in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204: 805–817.
5. Sacks DL, Lal SL, Shrivastava SN, Blackwell J, Neva FA, (1987) An analysis of T cell responsiveness in Indian kala-azar. J Immunol 138: 908–913.
6. Hailu A, van der Poll T, Berhe N, Kager PA, (2004) Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis. Am J Trop Med Hyg 71: 561–567.
7. Vouldoukis I, Becherel PA, Riveros-Moreno V, Arock M, da Silva O, et al. (1997) Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 27: 860–865.
8. Gidwani K, Jones S, Kumar R, Boelaert M, Sundar S, (2011) Interferon-gamma release assay (modified quantiferon) as a potential marker of infection for Leishmania donovani, a proof of concept study. Plos Negl Trop Dis 5: e1042.
9. Ansari NA, Kumar R, Gautam S, Nylen S, Singh OP, et al. (2011) IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol 186: 3977–3985.
10. Singh OP, Gidwani K, Kumar R, Nylen S, Jones SL, et al. (2012) Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol 19: 961–966.
11. Gautam S, Kumar R, Maurya R, Nylen S, Ansari N, et al. (2011) IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis 204: 1134–1137.
12. Abebe T, Takele Y, Weldegebreal T, Cloke T, Closs E, et al. (2013) Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia. Plos Negl Trop Dis 7: e2134.
13. Moreno Y, Gros PP, Tam M, Segura M, Valanparambil R, et al. (2011) Proteomic analysis of excretory-secretory products of Heligmosomoides polygyrus assessed with next-generation sequencing transcriptomic information. Plos Negl Trop Dis 5: e1370.
14. Maurya R, Mehrotra S, Prajapati VK, Nylen S, Sacks D, et al. (2010) Evaluation of blood agar microtiter plates for culturing leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis. J Clin Microbiol 48: 1932–1934.
15. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, et al. (2000) A natural model of Leishmania major infection reveals a prolonged “silent” phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165: 969–977.
16. Murray HW, (1990) Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis. J Infect Dis 161: 992–994.
17. Murray HW, Stern JJ, Welte K, Rubin BY, Carriero SM, et al. (1987) Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. J Immunol 138: 2290–2297.
18. Taylor AP, Murray HW, (1997) Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. J Exp Med 185: 1231–1239.
19. Gautam S, Kumar R, Singh N, Singh AK, Rai M, et al. (2013) CD8 T Cell Exhaustion in Human Visceral Leishmaniasis. J Infect Dis 209: 290–299.
20. Xu Y, mckenna RW, Karandikar NJ, Pildain AJ, Kroft SH, (2005) Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol 124: 799–806.
21. Fakiola M, Strange A, Cordell HJ, Miller EN, Pirinen M, et al. (2013) Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet 45: 208–213.
22. Murray HW, Oca MJ, Granger AM, Schreiber RD, (1989) Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis. J Clin Invest 83: 1253–1257.
23. Kenney RT, Sacks DL, Gam AA, Murray HW, Sundar S, (1998) Splenic cytokine responses in Indian kala-azar before and after treatment. J Infect Dis 177: 815–818.
24. Sundar S, Murray HW, (1995) Effect of treatment with interferon-gamma alone in visceral leishmaniasis. J Infect Dis 172: 1627–1629.
25. Sundar S, Singh VP, Sharma S, Makharia MK, Murray HW, (1997) Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. J Infect Dis 176: 1117–1119.